浏览全部资源
扫码关注微信
1.湖南中医药大学,长沙 410208
2.湖南中医药大学 第一附属医院,长沙 410007
Published:05 July 2023,
Published Online:28 October 2022,
Received:30 August 2022,
扫 描 看 全 文
胡雅琪,刘建和.中医药调控AMPK信号通路治疗心肌缺血再灌注损伤研究进展[J].中国实验方剂学杂志,2023,29(13):213-221.
HU Yaqi,LIU Jianhe.Traditional Chinese Medicine in Treatment of Myocardial Ischemia-Reperfusion Injury by Regulating Adenosine 5'-monophosphate (AMP)-activated Protein Kinase: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(13):213-221.
胡雅琪,刘建和.中医药调控AMPK信号通路治疗心肌缺血再灌注损伤研究进展[J].中国实验方剂学杂志,2023,29(13):213-221. DOI: 10.13422/j.cnki.syfjx.20230890.
HU Yaqi,LIU Jianhe.Traditional Chinese Medicine in Treatment of Myocardial Ischemia-Reperfusion Injury by Regulating Adenosine 5'-monophosphate (AMP)-activated Protein Kinase: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(13):213-221. DOI: 10.13422/j.cnki.syfjx.20230890.
急性心肌梗死因其高发病率及高死亡率严重危害居民健康,再灌注策略是急性心肌梗死的首选治疗策略,这些治疗措施能够快速恢复缺血心肌的血液循环,以挽救濒死的心肌细胞,减少心肌梗死面积,降低死亡率。然而再灌注可能会导致额外心脏损伤,即心肌缺血再灌注损伤(MIRI)。因此,如何减轻心肌缺血再灌注损伤成为心血管治疗急需解决的问题之一,中医药在治疗MIRI方面具有多成分、多途径、多靶点的优势,能为减轻心肌缺血再灌注损伤提供新的思路。腺苷酸活化蛋白激酶(AMPK)与MIRI密切相关,其可以通过调控炎症反应、氧化应激、自噬、凋亡和铁死亡等过程在减轻MIRI中发挥着重要作用。故该文综述了AMPK信号通路的基本结构及其在心肌缺血再灌注损伤中的作用,以及目前中医药通过调控AMPK通路治疗MIRI的研究进展,以期为心肌缺血再灌注损伤的防治提供一定的理论基础。
Due to its high incidence and mortality rate, acute myocardial infarction poses a serious threat to public health. Reperfusion therapy is the preferred treatment strategy for acute myocardial infarction, which can quickly restore blood circulation to the ischemic myocardium, rescue dying myocardial cells, reduce infarct size, and lower the mortality rate. However, reperfusion may lead to additional heart damage, known as myocardial ischemia-reperfusion injury (MIRI). Therefore, how to alleviate MIRI has become one of the urgent issues in cardiovascular therapy. Traditional Chinese medicine (TCM) has the advantage of multiple components, multiple pathways, and multiple targets in the treatment of MIRI, providing new ideas for reducing MIRI. Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) is closely related to MIRI, and it plays an important role in alleviating MIRI by regulating inflammation, oxidative stress, autophagy, apoptosis, and ferroptosis. This article reviewed the basic structure of the AMPK signaling pathway and its role in MIRI, as well as the research progress of TCM in the treatment of MIRI by regulating the AMPK pathway, aiming to provide a theoretical basis for the prevention and treatment of MIRI.
腺苷酸活化蛋白激酶(AMPK)信号通路中医药心肌缺血再灌注损伤研究进展
adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) signaling pathwaytraditional Chinese medicinemyocardial ischemia reperfusion injuryresearch progress
中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J].中国循环杂志,2021,36(6):521-545.
JIA X,SHAO W,TIAN S.Berberine alleviates myocardial ischemia-reperfusion injury by inhibiting inflammatory response and oxidative stress:The key function of miR-26b-5p-mediated PTGS2/MAPK signal transduction[J].Pharm Biol,2022,60(1):652-663.
NERI M,RIEZZO I,PASCALE N,et al.Ischemia/reperfusion injury following acute myocardial infarction:A critical issue for clinicians and forensic pathologists[J].Mediators Inflamm,2017,2017:7018393.
GU C,LI T,JIANG S,et al.AMP-activated protein kinase sparks the fire of cardioprotection against myocardial ischemia and cardiac ageing[J].Ageing Res Rev,2018,47:168-175.
DAY E A,FORD R J,STEINBERG G R.AMPK as a therapeutic target for treating metabolic diseases[J].Trends Endocrinol Metab,2017,28(8):545-560.
KHAN H,GUPTA A,SINGH T G,et al.Mechanistic insight on the role of leukotriene receptors in ischemic-reperfusion injury[J].Pharmacol Rep,2021,73(5):1240-1254.
ONG S B,HERNÁNDEZ-RESÉNDIZ S,CRESPO-AVILAN G E,et al.Inflammation following acute myocardial infarction:Multiple players,dynamic roles,and novel therapeutic opportunities[J].Pharmacol Ther,2018,186:73-87.
PEARCE L,DAVIDSON S M,YELLON D M.Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response[J].Basic Res Cardiol,2021,116(1):12.
WARD A O,CAPUTO M,ANGELINI G D,et al.Activation and inflammation of the venous endothelium in vein graft disease[J].Atherosclerosis,2017,265:266-274.
CHEN X,LI X,ZHANG W,et al.Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway[J].Metabolism,2018,83:256-270.
MORIS D,SPARTALIS M,TZATZAKI E,et al.The role of reactive oxygen species in myocardial redox signaling and regulation[J].Ann Transl Med,2017,5(16):324.
CSONKA C,SÁRKÖZY M,PIPICZ M,et al.Modulation of Hypercholesterolemia-induced oxidative/nitrative stress in the heart[J].Oxid Med Cell Longev,2016,2016:3863726.
LU Q,LI X,LIU J,et al.AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases[J].Biosci Rep,2019,doi:10.1042/BSR20181995http://dx.doi.org/10.1042/BSR20181995.
CADENAS S.ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection[J].Free Radic Biol Med,2018,117:76-89.
LV Z,WANG F,ZHANG X,et al.Etomidate attenuates the ferroptosis in myocardial ischemia/reperfusion rat model via Nrf2/HO-1 pathway[J].Shock,2021,56(3):440-449.
LIU Y,ZHAO Y B,WANG S W,et al.Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway[J].Int J Mol Med,2017,40(3):913-921.
ZHAI M,LI B,DUAN W,et al.Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis[J].J Pineal Res,2017,doi:10.1111/jpi.12419http://dx.doi.org/10.1111/jpi.12419.
CAI Y,YING F,LIU H,et al.Deletion of Rap1 protects against myocardial ischemia/reperfusion injury through suppressing cell apoptosis via activation of STAT3 signaling[J].FASEB J,2020,34(3):4482-4496.
PEI H,QU Y,LU X,et al.Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling[J].Basic Res Cardiol,2013,108(1):322.
NAM D H,HAN J H,KIM S,et al.Activated protein C prevents methylglyoxal-induced endoplasmic reticulum stress and cardiomyocyte apoptosis via regulation of the AMP-activated protein kinase signaling pathway[J].Biochem Biophys Res Commun,2016,480(4):622-628.
WU Y,LIU H,WANG X.Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury[J].Life Sci,2021,264:118628.
KROEMER G,LEVINE B.Autophagic cell death:The story of a misnomer[J].Nat Rev Mol Cell Biol,2008,9(12):1004-1010.
PARADIES G,PARADIES V,RUGGIERO F M,et al.Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury:Implications for pharmacological cardioprotection[J].Am J Physiol Heart Circ Physiol,2018,315(5):H1341-H1352.
KIM Y C,GUAN K L.mTOR:A pharmacologic target for autophagy regulation[J].J Clin Invest,2015,125(1):25-32.
ZHOU B,LENG Y,LEI S Q,et al.AMPK activation restores ischemic post‑conditioning cardioprotection in STZ‑induced type 1 diabetic rats:Role of autophagy[J].Mol Med Rep,2017,16(3):3648-3656.
WANG Y,SUN H,SONG J,et al.MiR-139-5p protect against myocardial ischemia and reperfusion (I/R) injury by targeting autophagy-related 4D and inhibiting AMPK/mTOR/ULK1 pathway[J].Int J Clin Exp Pathol,2017,10(9):10140-10151.
WU X,LI Y,ZHANG S,et al.Ferroptosis as a novel therapeutic target for cardiovascular disease[J].Theranostics,2021,11(7):3052-3059.
LILLO-MOYA J,ROJAS-SOLÉ C,MUÑOZ-SALAMANCA D,et al.Targeting ferroptosis against ischemia/reperfusion cardiac injury[J].Antioxidants (Basel),2021,10(5):667.
PARK T J,PARK J H,LEE G S,et al.Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes[J].Cell Death Dis,2019,10(11):835.
TONELLI C,CHIO I,TUVESON D A.Transcriptional regulation by Nrf2[J].Antioxid Redox Signal,2018,29(17):1727-1745.
ZHANG D D.Mechanistic studies of the Nrf2-Keap1 signaling pathway[J].Drug Metab Rev,2006,38(4):769-789.
LU H,XIAO H,DAI M,et al.Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling[J].Pharm Biol,2022,60(1):38-45.
ZHOU T,PRATHER E R,GARRISON D E,et al.Interplay between ROS and antioxidants during ischemia-reperfusion injuries in cardiac and skeletal muscle[J].Int J Mol Sci,2018,19(2):417.
XIANG M,LU Y,XIN L,et al.Role of oxidative stress in reperfusion following myocardial ischemia and its treatments[J].Oxid Med Cell Longev,2021,2021:6614009.
YU Y,YAN Y,NIU F,et al.Ferroptosis:A cell death connecting oxidative stress,inflammation and cardiovascular diseases[J].Cell Death Discov,2021,7(1):193.
任钧国,马晓斌,林成仁,等.加味生脉散对急性心肌缺血再灌注损伤大鼠的保护作用[J].中国实验方剂学杂志,2010,16(2):78-80.
LI F,ZHENG X,FAN X,et al.YiQiFuMai powder injection attenuates ischemia/reperfusion-induced myocardial apoptosis through AMPK activation[J].Rejuvenation Res,2016,19(6):495-508.
XING Z,XIA Z,PENG W,et al.Xuefu Zhuyu decoction,a traditional Chinese medicine,provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway[J].Sci Rep,2016,6:20040.
SHI X,ZHU H,ZHANG Y,et al.XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy[J].BMC Complement Altern Med,2017,17(1):325.
ZHANG Q G,WANG S R,CHEN X M,et al.Dunye Guanxinning improves acute myocardial ischemia-reperfusion injury by inhibiting neutrophil infiltration and Caspase-1 activity[J].Mediators Inflamm,2018,2018:4608017.
余萍,李敏,郭俐宏.丹红注射液对大鼠实验性心肌缺血再灌注损伤血管内皮生长因子表达的影响[J].辽宁中医药大学学报,2015,17(12):35-38.
田心,王渊博.丹红注射液激活AMPK保护心肌缺血再灌注损伤模型大鼠的实验研究[J].中国中医急症,2017,26(12):2083-2085,2138.
CHEN L,LIU P,FENG X,et al.Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo[J].J Cell Mol Med,2017,21(12):3178-3189.
ZHAO J,ZHANG J,LIU Q,et al.Hongjingtian injection protects against myocardial ischemia reperfusion-induced apoptosis by blocking ROS induced autophagic-flux[J].Biomed Pharmacother,2021,135:111205.
CUI Y,WANG Y,LIU G.Protective effect of barbaloin in a rat model of myocardial ischemia reperfusion injury through the regulation of the CNPY2‑PERK pathway[J].Int J Mol Med,2019,43(5):2015-2023.
ZHANG P,LIU X,HUANG G,et al.Barbaloin pretreatment attenuates myocardial ischemia-reperfusion injury via activation of AMPK[J].Biochem Biophys Res Commun,2017,490(4):1215-1220.
TIAN Y,DU Y Y,SHANG H,et al.Calenduloside E analogues protecting H9c2 cardiomyocytes against H2O2-induced apoptosis:Design,synthesis and biological evaluation[J].Front Pharmacol,2017,8:862.
WANG S,TIAN Y,ZHANG J Y,et al.Targets fishing and identification of Calenduloside E as Hsp90AB1:Design,synthesis,and evaluation of clickable activity-based probe[J].Front Pharmacol,2018,9:532.
WANG M,WANG R Y,ZHOU J H,et al.Calenduloside E ameliorates myocardial ischemia-reperfusion injury through regulation of AMPK and mitochondrial OPA1[J].Oxid Med Cell Longev,2020,2020:2415269.
TIAN X,HUANG Y,ZHANG X,et al.Salidroside attenuates myocardial ischemia/reperfusion injury via AMPK-induced suppression of endoplasmic reticulum stress and mitochondrial fission[J].Toxicol Appl Pharmacol,2022,448:116093.
姜丽.AMPK-NF-κB通路介导的三七总皂苷抗心肌缺血再灌注炎症反应的机制研究[D].上海:上海中医药大学,2016.
CHEN B,LONGTINE M S,NELSON D M.Punicalagin,a polyphenol in pomegranate juice,downregulates p53 and attenuates hypoxia-induced apoptosis in cultured human placental syncytiotrophoblasts[J].Am J Physiol Endocrinol Metab,2013,305(10):E1274-E1280.
DING M,WANG Y,SUN D,et al.Punicalagin pretreatment attenuates myocardial ischemia-reperfusion injury via activation of AMPK[J].Am J Chin Med,2017,45(1):53-66.
施蛟,陈博,孙智华,等.中间锦鸡儿黄酮类成分的研究[J].药学学报,2003,38(8):599-602.
段佳林,奚苗苗,牟菲,等.紫铆花素通过调节AMPK/GSK-3β信号通路抑制心肌缺血再灌注损伤[J].现代生物医学进展,2017,17(14):2616-2621.
ZHU N,CAO X,HAO P,et al.Berberine attenuates mitochondrial dysfunction by inducing autophagic flux in myocardial hypoxia/reoxygenation injury[J].Cell Stress Chaperones,2020,25(3):417-426.
CHANG W,ZHANG M,LI J,et al.Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5'-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart[J].Cardiovasc Drugs Ther,2012,26(6):467-478.
HAN D,WEI J,ZHANG R,et al.Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling[J].Sci Rep,2016,6:35319.
WANG X,MA Z,FU Z,et al.Hydroxysafflor yellow A protects neurons from excitotoxic death through inhibition of NMDARs[J].ASN Neuro,2016,doi:10.1177/1759091416642345http://dx.doi.org/10.1177/1759091416642345.
YE J,LU S,WANG M,et al.Hydroxysafflor yellow A protects against myocardial ischemia/reperfusion injury via suppressing NLRP3 inflammasome and activating autophagy[J].Front Pharmacol,2020,11:1170.
WAN S,ZHANG J,HOU R,et al.A strategy for component-based Chinese medicines design approach of Polygonum orientale L. against hypoxia/reoxygenation based on uniform design-stepwise regression-simulated annealing[J].Biomed Pharmacother,2021,135:111177.
LIU L,WU Y,HUANG X.Orientin protects myocardial cells against hypoxia-reoxygenation injury through induction of autophagy[J].Eur J Pharmacol,2016,776:90-98.
SHAO H,FANG C,HUANG Y,et al.Sodium tanshinone ⅡA sulfonate injection as adjunctive therapy for the treatment of heart failure:A systematic review and meta-analysis[J].Phytomedicine,2022,95:153879.
焦守峰.AMPKα2介导丹参酮ⅡA抗心肌缺血/再灌注损伤的机制研究[D].南昌:南昌大学,2016.
ZHU X,WANG K,ZHOU F,et al.Paeoniflorin attenuates atRAL-induced oxidative stress,mitochondrial dysfunction and endoplasmic reticulum stress in retinal pigment epithelial cells via triggering Ca2+/CaMKⅡ-dependent activation of AMPK[J].Arch Pharm Res,2018,41(10):1009-1018.
高宇勤,郝霁萍,赵国平.芍药苷预处理激活AMPKα对在体大鼠心肌缺血再灌注损伤的保护作用[J].海南医学,2015(15):2185-2188,2189.
PARK E S,KANG D H,YANG M K,et al.Cordycepin,3'-deoxyadenosine,prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression[J].Cardiovasc Toxicol,2014,14(1):1-9.
XU H,CHENG J,HE F.Cordycepin alleviates myocardial ischemia/reperfusion injury by enhancing autophagy via AMPK-mTOR pathway[J].J Physiol Biochem,2022,78(2):401-413.
0
Views
30
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution